Canella et al., 2017 - Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide Against Malignant Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research   23(20):6215-6226 Full text @ Clin. Cancer Res.
Human Disease / Model Data (1 Record)
Human Disease Fish Environment Evidence Code
brain glioma WT cancer xenotransplantation
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.